Share Prices & Company Research

Stockbroking

BTG

Current Price 839.42p Bid 839.50p Ask 840.00p Change 0.00%
Last Updated: 19/08/2019 07:10. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

BTG plc is a global specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. It has a portfolio of Interventional Medicine products to advance the treatment of cancer, severe emphysema, severe blood clots and varicose veins, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today's most complex healthcare challenges.

Financial Highlights Year Ended 31/03/2019

Turnover
£914.10m
Operating Profit
£128.00m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
29.15

Key Personnel

Dr Pamela Louise Makin
Chief Executive Officer
Duncan Kennedy
Chief Financial Officer
Richard Leslie Martin Wohanka
Non-Executive Director
Anne Devine Thorburn
Non-Executive Director
William James O`Shea
Non-Executive Director
Ian Fraser Robert Much
Non-Executive Director
Graham Charles Hetherington
Non-Executive Director
Dr Susan Elizabeth Foden
Non-Executive Director
Gregory Ackley Barrett
Non-Executive Director

Stock Details

EPIC
BTG
ISIN
GB0001001592
Shares in Issue
388,252,315
Market cap
£3,259.38m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
840.00p
Bid Price
839.50p
Ask Price
840.00p
Volume
0
Change Today
0.00p
% Change Today
0.00%
Open
839.50p
Previous Close
840.00p
Intraday High
0.00p
Intraday Low
0.00p
52 Week High
853.00p
52 Week Low
507.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

BTG Intra-day Chart

BTG News

News in this section is provided by AJ Bell

Director Deals - BTG PLC (BTG) 16 Aug 2019 | 17:20 Director Deals - BTG PLC (BTG) 16 Aug 2019 | 17:15 Director Deals - BTG PLC (BTG) 16 Aug 2019 | 17:15 Director Deals - BTG PLC (BTG) 16 Aug 2019 | 17:05 Director Deals - BTG PLC (BTG) 16 Aug 2019 | 17:00 Director Deals - BTG PLC (BTG) 16 Aug 2019 | 16:55 BTG shares to cease trading on 19 August as Boston Scientific set to complete takeover 07 Aug 2019 | 08:59 BTG, Boston Scientific agree to sell existing drug-eluting and bland embolic microsphere business to Varian Medical Systems 02 Jul 2019 | 08:03 UK stocks slip in light pre-holiday trading 18 Apr 2019 | 09:22 BTG reports product sales at upper end of guidance; licensing revenues flat 18 Apr 2019 | 07:40 Director Deals - BTG PLC (BTG) 26 Nov 2018 | 15:35 FTSE slips on Brexit and trade war fears 20 Nov 2018 | 17:02 Boston Scientific agrees to acquire BTG for £3.3bn 20 Nov 2018 | 13:46 FTSE recovers some ground despite long list of global concerns 20 Nov 2018 | 12:03 Broker Forecast - Peel Hunt issues a broker note on BTG PLC 16 Nov 2018 | 08:10 Broker Forecast - JP Morgan Cazenove issues a broker note on BTG PLC 14 Nov 2018 | 10:00 FTSE subdued on falling oil prices and strong sterling 13 Nov 2018 | 16:51 BTG upgrades pharmaceuticals sales outlook following strong first half 13 Nov 2018 | 07:42 Broker Forecast - RBC Capital Markets issues a broker note on BTG PLC 16 Oct 2018 | 10:50 FTSE falls amid concerns around interest rate hikes and Brexit 04 Oct 2018 | 16:44 Interest rate hike speculation hits FTSE 04 Oct 2018 | 11:48 UK stocks start 0.8% lower as bearish Asian sentiment weighs 04 Oct 2018 | 09:48 BTG upgrades sales outlook following strong first-half performance 04 Oct 2018 | 09:45 Global markets stall on re-ignited trade war fears 07 Sep 2018 | 16:51 BTG buys medical device company Novate for up to $150m 07 Sep 2018 | 13:00 FTSE falls on retreating banks and miners 07 Sep 2018 | 11:58

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Tangible Assets
55.5
40.7
Intangible Assets & Goodwill
876.7
686.8
Investments & Other Non-Current Assets
65.9
27.2
Total Non-Current Assets
998.1
754.7
Inventory
104.8
61.0
Trade & Receivables
216.0
134.0
Cash & Receivables
351.4
210.0
Other Current Assets & Assets Held for Resale
4.1
3.0
Total Assets
1,674.4
1,162.7

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Short Term Liabilities
222.0
190.1
Long Term Liabilities
75.7
59.8
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
297.7
249.9

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Net Assets
1,376.7
912.8

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Share Capital
61.5
38.6
Minority Interests
0.0
-1.9
Retained Earnings
238.9
90.7
Share Premium Account
674.4
437.7
Other Equity
401.9
347.7
Total Equity
1,376.7
912.8

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Cashflow from Operating Activities
134.9
120.7
Cashflow Before Financing
84.3
64.3
Increase / Decrease in Cash
63.3
63.3

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Turnover
914.1
620.5
Cost of Sales
276.2
185.9
Gross Profit
637.9
434.6
Operating Profit
128.0
-102.8
Pre-Tax Profit
108.2
-70.6
Profit / Loss for the Year
110.4
12.7
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.